Opinion: Invoking Bayh-Dole may be needed to get affordable Covid-19 treatments
As the Covid-19 pandemic strains the capacity of the U.S. health care system, attention is being focused on developing new drugs and therapies to fight it.
Pharmaceutical company Moderna, for example, began clinical trials in Seattle for a new vaccine, providing welcome news to many. But what few Americans realize is just how much of their taxpayer dollars went into the development of these drugs long before Covid-19 emerged.
